Covaé: Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020

• Sponsor: Direction Centrale du Service de Santé des Armées (Other)
• Overall Status: Completed
• CT.gov ID: NCT04514874
• Collaborator: (none)
• Enrollment: 479
• Locations: 2
• Actual Duration (Months): 1.1
• Patients Per Site: 239.5
• Patients Per Site Per Month: 214.4

Study Details

Study Description

Brief Summary

The aeronautical community was also affected and greatly impacted economically and socially by the Covid-19 pandemic. Away from the acute phase, the epidemiological impact and the consequences of this disease within the French aviation flight crew population must be assessed. This study is aimed at providing original epidemiological data among civil and military aircrew, prior to possible prevention strategies or countermeasures to optimize risk management in terms of aviation safety and to promote, if necessary, future targeted studies.

Condition or Disease	Intervention/Treatment	Phase
Covid19; SARS-CoV Infection	Other: Questionnaire

Study Design

• Study Type: Observational
• Actual Enrollment: 479 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Assessment of the Prevalence and the Impact of the COVID-19 Epidemic in the French Flight Crew in 2020
• Actual Study Start Date: Sep 1, 2020
• Actual Primary Completion Date: Oct 5, 2020
• Actual Study Completion Date: Oct 5, 2020

Outcome Measures

Primary Outcome Measures

1. Prevalence of COVID-19 infection among French military professional aircrew [At enrollment]

   Prevalence of COVID-19 infection will be estimated on the basis of the replies to the questionnaire

Secondary Outcome Measures

1. Predictive factors of COVID-19 infection [At enrollment]

   Predictive factors of COVID-19 infection will be assessed using a top-down logistic regression model taking into account socio-demographic and occupational variables.

2. Techniques used for COVID-19 screening [At enrollment]

   Techniques used for COVID-19 screening will be estimated on the basis of the replies to the questionnaire (among participants who reported being tested for COVID-19)

3. Reasons for COVID-19 screening [At enrollment]

   Reasons for COVID-19 screening will be estimated on the basis of the replies to the questionnaire (among participants who reported being tested for COVID-19)

4. Experienced symptoms of COVID-19 [At enrollment]

   Experienced symptoms of COVID-19 will be estimated on the basis of the replies to the questionnaire (among participants who reported being infected)

5. Medical care of COVID-19 [At enrollment]

   Medical care of COVID-19 will be estimated on the basis of the replies to the questionnaire (among participants who reported being infected)

6. Social consequences of the COVID-19 pandemic [At enrollment]

   Social consequences of the COVID-19 pandemic will be estimated on the basis of the replies to the questionnaire

7. Factors associated with pejorative consequences of the COVID-19 pandemic [At enrollment]

   Factors associated with pejorative consequences of the COVID-19 pandemic will be assessed using a top-down logistic regression model taking into account socio-demographic and occupational variables.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• At least 18 years of age

• Professional military aircrew

• Presenting himself/herself for a periodic medical exam

Exclusion Criteria:

• Under 18 years of age

• Parachutists

• Non-professional aircrew

• Presenting himself/herself for a first medical exam

• Pregnant woman, parturient, breastfeeding

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Percy	Clamart		France	92140
2	Centre d'Expertise Medicale du Personnel Navigant (CEMPN) de l'Hôpital d'Instruction des Armées Sainte-Anne	Toulon		France	83000

Sponsors and Collaborators

• Direction Centrale du Service de Santé des Armées

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Direction Centrale du Service de Santé des Armées
• ClinicalTrials.gov Identifier: NCT04514874
• Other Study ID Numbers: 2020-COVID19-26; 2020-A01459-30
• First Posted: Aug 17, 2020
• Last Update Posted: Mar 9, 2021
• Last Verified: Mar 1, 2021

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: COVID-19; Severe Acute Respiratory Syndrome

Study Results

No Results Posted as of Mar 9, 2021